Company Filing History:
Years Active: 2019-2025
Title: Innovations in Radiotherapy: The Contributions of Christopher G Thomas
Introduction
Christopher G Thomas is a notable inventor based in Halifax, Canada, recognized for his significant contributions to the field of radiotherapy. With a total of five patents to his name, Thomas has been at the forefront of developing advanced methods and systems that enhance the precision and effectiveness of radiation treatment.
Latest Patents
Among his latest patents is a groundbreaking system titled "Systems and methods for planning, controlling and/or delivering radiotherapy and radiosurgery using combined optimization of dynamic axes (CODA)." This innovative approach utilizes a CODA cube for radiation treatment planning and delivery, optimizing couch, collimator, and gantry angles simultaneously. The results demonstrate substantial benefits over conventional VMAT techniques, including a statistically significant reduction in maximum radiation doses to organs at risk (OARs) by 20.6%. Additionally, the maximum radiation dose to the brainstem was decreased by an average of 2.63 Gy. Another notable patent is "Coordinated radiotherapy for plural targets," which introduces a method for generating treatment plans that allow for the omission of certain target volumes, thereby minimizing radiation exposure to non-target tissues.
Career Highlights
Christopher G Thomas is affiliated with Dalhousie University, where he continues to advance research in radiotherapy. His work has not only contributed to the academic community but has also had a profound impact on clinical practices in radiation treatment.
Collaborations
Thomas has collaborated with esteemed colleagues such as Robert Lee MacDonald and Alasdair Syme, further enhancing the scope and impact of his research in the field.
Conclusion
Christopher G Thomas exemplifies the spirit of innovation in radiotherapy, with his patents paving the way for more effective and safer treatment options. His contributions are invaluable to both the scientific community and patients receiving radiation therapy.